[PHARMACOLOGY OF TETRAHYDROPAPAVEROLINE AND ITS FORMATION FROM DOPAMINE].
D000818:Animals; D000959:Antihypertensive Agents; D004298:Dopamine; D007793:Lagomorpha; D008055:Lipids / Q000097:blood*; D008660:Metabolism; D008996:Monoamine Oxidase Inhibitors; D010208:Papaverine; D010600:Pharmacology; D011817:Rabbits; D051381:Rats; D012106:Research; D011984:Sensory Receptor Cells; D013765:Tetrahydropapaveroline; D014666:Vasomotor System
D000959:Antihypertensive Agents; D008055:Lipids; D008996:Monoamine Oxidase Inhibitors; D013765:Tetrahydropapaveroline; D010208:Papaverine; D004298:Dopamine
ANTIHYPERTENSIVE AGENTS; BLOOD LIPIDS; DOPAMINE; EXPERIMENTAL LAB STUDY; METABOLISM; MONOAMINE OXIDASE INHIBITORS; PAPAVERINE; PHARMACOLOGY; RABBITS; RATS; RECEPTORS, NEURAL; VASOMOTOR SYSTEM
PHARMAKOLOGIE DES TETRAHYDROPAPAVEROLINS UND SEINE ENTSTEHUNG AUS DOPAMIN.